The NHS is being called upon to swiftly update its online resources after the widespread renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). This change, which impacts approximately one in eight women, follows a 14-year collaboration among medical experts, advocacy groups, and those personally affected by the condition. The absence of the new nomenclature on the NHS website has raised concerns about potential confusion among patients seeking support and information.
Call for Clarity from Advocacy Groups
Neelam Heera-Shergill, the CEO and founder of the charity Cysters, has emphasised the necessity for the NHS to act promptly. “As an organisation rooted in reproductive and health justice, we welcome conversations around language that better reflect the realities and experiences of those living with PMOS/PCOS. But any name change must go beyond symbolism,” she stated.
Heera-Shergill underscored the importance of providing accessible and timely information, especially for those from marginalised backgrounds who often encounter barriers in healthcare. “Communities deserve clear communication so they are not left confused, excluded, or struggling to access vital support and diagnosis,” she added.
Transition Period: A Double-Edged Sword
Despite the positive reception of the new name, the announcement has been accompanied by a three-year transition plan. Caroline Andrews, a trustee of Verity, acknowledged the challenges of this timeline. “We fully appreciate that they [the NHS] need transition time just like we do,” she remarked, noting the various ongoing changes within the NHS itself, including the recent appointment of a new health secretary and the launch of the renewed Women’s Health Strategy for England.
With the UK National Institute for Health and Care Excellence (NICE) set to release its first standalone guidelines for PMOS/PCOS later this year, Andrews expressed the need for careful and thoughtful implementation. “We’d much rather the NHS do this carefully, considering all lines of care,” she added.
Expert Opinions on the Name Change
Prof Channa Jayasena, a reproductive endocrinology expert at Imperial College London, has welcomed the renaming as a significant step forward. “It’s a tremendous initiative,” he said, highlighting its potential to enhance understanding among women and clinicians alike regarding the condition’s seriousness. However, he also cautioned that it will take time for the change to be universally recognized within the medical community.
“There’s a long history of many conditions still being referred to by outdated names, and not all clinicians are aware of the latest terminology,” he pointed out, acknowledging that patients may inadvertently encounter confusion as a result.
The Need for Immediate Updates
Dr Sophie Williams, a mental health expert at the University of Derby, echoed these concerns, suggesting that the current NHS website’s continued reference to PCOS could undermine public trust. “When you see ‘polycystic ovaries’ on the NHS site, it may lead you to question the legitimacy of the information,” she said, emphasising that the NHS is typically a primary source for health care advice.
Williams proposed the idea of creating dual shadow webpages—one for PCOS and another for PMOS—linking them to guide the public more effectively through the transition. “The sooner all of those reliable sources align, the clearer the messaging will be for individuals seeking accurate information,” she concluded.
An NHS spokesperson addressed these concerns, stating, “We routinely review and update content on the NHS website to ensure it reflects the latest clinical advice and will carefully consider these recommendations.” They also reaffirmed their commitment to improving women’s healthcare.
Why it Matters
The renaming of PCOS to PMOS represents a significant shift in how this condition is perceived and treated. This change has the potential to foster greater understanding and empathy towards those affected, especially in a healthcare system that has historically struggled with inclusivity. By ensuring that all resources are updated and accurate, the NHS can help bridge the gap between medical understanding and patient experience, ultimately leading to better health outcomes for women facing this condition. The urgency for clarity is not just about semantics; it is about ensuring that every woman has access to the care and support she deserves.
